Kidney Disease News and Research

RSS

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

From Calluna Pharma 24 Jan 2024

Blood pressure variability: A stronger marker for Alzheimer's risk than heart rate variability

Study finds that clinically derived blood pressure variability (BPV), rather than heart rate variability (HRV), is more strongly associated with the risk of Alzheimer’s Disease and Related Dementias (ADRD).

23 Jan 2024

Study uncovers 23 new genetic markers linked to kidney health on the X-chromosome

A meta-analysis of 908,697 samples to investigate the genetic, sex-dependent basis of kidney traits.

23 Jan 2024

Wearable blood pressure monitoring for assessing remote blood pressure regulation

The prevalence of controlled hypertension using a wearable blood pressure (BP) device.

23 Jan 2024

The long-term outcomes of diabetes remission and its impact on health

Researchers examine the effect of diabetes remission on long-term health outcomes.

23 Jan 2024

NHS Health Check linked to lower disease rates and mortality, study shows

Attending an NHS Health Check appointment -; a preventative screening programme offered for free in the UK -; is associated with both a decreased risk of dying and a decreased risk of several diseases, including dementia and liver cirrhosis.

22 Jan 2024

Scientists discover new genetic cause of inherited kidney disease

Genetic changes or mutations can cause hereditary kidney disease, which can eventually lead to dialysis or the need for kidney transplantation. Identifying the cause of inherited kidney disease is the first step in identifying a treatment.

22 Jan 2024

Cancer drug holds promise for shrinking polycystic kidney cysts

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function.

22 Jan 2024

Study shows lasting benefits of weight loss and diabetes remission for the heart and kidneys

Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.

22 Jan 2024

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Researchers investigate the need for prioritizing COVID-19 booster vaccination.

19 Jan 2024

Study provides new evidence of weight loss benefits for type 2 diabetes patients

18 Jan 2024

Remission of diabetes from weight-loss significantly reduces cardiovascular disease risk

While several trials have shown that substantial weight loss using diet and lifestyle can reverse type 2 diabetes, new research published in Diabetologia (the journal of the European Association of the Study of Diabetes [EASD]) is among the first to show the subsequent impact of remission on cardiovascular outcomes.

18 Jan 2024

Chronic kidney and cardiovascular disease threaten burn victims' survival

Despite enormous medical advances, severe burns are still potentially life-threatening injuries. Clinical scores, which take relevant parameters into account, are available to doctors as a decision-making aid for therapeutic measures and to assess the probability of patient survival.

17 Jan 2024

Study links teenage stress to cardiometabolic risk later in life

Young adults who reported higher stress during their teenage years to adulthood were more likely to have high blood pressure, obesity and other cardiometabolic risk factors than their peers who reported less stress, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

17 Jan 2024

Chronic inflammation and poverty join forces to increase mortality risk

A new study led by a University of Florida College of Public Health and Health Professions researcher finds that people with chronic inflammation living in poverty have more than double the risk of dying from heart disease and nearly triple the risk of dying from cancer within the next 15 years.

16 Jan 2024

Kidney Disease News and Research

Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Blood pressure variability: A stronger marker for Alzheimer's risk than heart rate variability

Study uncovers 23 new genetic markers linked to kidney health on the X-chromosome

Wearable blood pressure monitoring for assessing remote blood pressure regulation

The long-term outcomes of diabetes remission and its impact on health

NHS Health Check linked to lower disease rates and mortality, study shows

Scientists discover new genetic cause of inherited kidney disease

Cancer drug holds promise for shrinking polycystic kidney cysts

Study shows lasting benefits of weight loss and diabetes remission for the heart and kidneys

The crucial need for ongoing COVID-19 booster vaccination in vulnerable populations

Study provides new evidence of weight loss benefits for type 2 diabetes patients

Remission of diabetes from weight-loss significantly reduces cardiovascular disease risk

Chronic kidney and cardiovascular disease threaten burn victims' survival

Study links teenage stress to cardiometabolic risk later in life

Chronic inflammation and poverty join forces to increase mortality risk

Migraine linked to increased risk of inflammatory bowel disease in new study

Dark chocolate cuts hypertension risk: Sweet news from latest study

Prenatal weather exposure could affect future blood pressure of the unborn child

Bariatric surgery may mitigate the natural history of cognitive decline in people with obesity

GLP-1R agonist liraglutide rapidly improves insulin sensitivity in pre-diabetics, independent of weight loss

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News